<img alt="" src="https://secure.lote1otto.com/219869.png" style="display:none;">
Skip to content

Perspectives on Enquiry & Evidence

Cytel's blog featuring the latest industry insights.

Aligning Clinical Trial Design with Investment Priorities

When working with investors, it’s critical that drug and device developers consider how their clinical trial design aligns with investment priorities. Natalia Muehlemann and Ari Brettman (Blackstone Life Sciences) discuss what investors look for when evaluating clinical development programs, and the value of simulation-guided design in informing decisions and facilitating communication with investors.

Read full article
Perspectives on Enquiry and Evidence
November 5, 2015

The 24 Hour Work Day

Oftentimes people perceive a tradeoff between speed and quality. The faster you do something the more likely you are to...
Read article
October 7, 2014

You Own This!

Guest blogger Laurie Halloran is the President and CEO of Halloran Consulting Group, a management consulting firm for...
Read article
contact iconSubscribe back to top